The department's provider integrity unit shall monitor utilization of pharmaceutical services to identify, prevent, and correct potential occurrences of fraud, waste, and abuse in accordance with 42 CFR 455, 42 CFR 456, and He-W 520.
N.H. Admin. Code § He-W 570.11
(See Revision Note at chapter heading He-W 500); ss by #5742, eff 12-1-93, EXPIRED: 12-1-99
New. #7392, eff 10-28-00; ss by #7680, eff 4-20-02; ss by #7712, INTERIM, eff 6-22-02, EXPIRES: 12-19-02
New. #7805, eff 12-21-02; ss by #9831, eff 12-21-10